Westpac Banking Corp
WBC
CommBank
CBA
Fortescue Ltd
FMG
Rio Tinto Ltd
RIO
National Australia Bank Ltd
NAB
AU Stock MarketDetailed Quotes
PER Percheron Therapeutics Ltd
- 0.008
- +0.001+14.29%
20min DelayMarket Closed Dec 27 16:00 AET
8.70MMarket Cap-0.57P/E (Static)
0.008High0.007Low20.51MVolume0.007Open0.007Pre Close161.16KTurnover0.14052wk High2.30%Turnover Ratio1.09BShares0.00552wk Low-0.014EPS TTM7.13MFloat Cap0.140Historical HighLossP/E (Static)891.65MShs Float0.005Historical Low-0.014EPS LYR14.29%Amplitude--Dividend TTM0.89P/B1Lot Size--Div YieldTTM
About Percheron Therapeutics Ltd Company
Percheron Therapeutics Ltd is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The company operates into two operating segment: ATL1102 and ATL1103. Key revenue is generated from ATL1102.
Company Profile
SymbolPER
Company NamePercheron Therapeutics Ltd
Founded2000
MarketASX
Employees3
Fiscal Year Ends06-30
Address14 Wallace Avenue LEVEL 1
CityToorak
CountryAustralia
Zip Code3142
Phone+61 398278999
Websitehttps://www.percherontx.com
Share RegistryBOARDROOM PTY LIMITED
LEVEL 8, 210 GEORGE STREET, SYDNEY, NSW, AUSTRALIA, 2000
(02) 9290 9600
Company Executives
- Name
- Position
- Salary
- James Garner
- Chief Executive Officer,Managing Director
- --
- Charmaine Gittleson
- Executive Chairman,Executive Director
- --
- Ben Gil Price
- Non-Executive Director
- --